Semler Scientific
Jennifer Oliva Herrington has a diverse work experience spanning over several companies and roles. Jennifer is currently serving as the Chief Operating Officer at Semler Scientific, a position they have held since December 2022. Prior to this role, Jennifer held positions including Chief Revenue Officer, Senior Vice President of Enterprise Business, VP of Enterprise Solutions, and Director of Business Development at Semler Scientific, starting from October 2010 until September 2020. Before joining Semler Scientific, Jennifer worked as an Independent Consultant/Owner at Alternative Solutions from 2008 to 2010. Jennifer also served as a Territory Sales Manager at FUJIFILM SonoSite, Inc. from 2001 to 2007 and as an Area Sales Manager at Stryker from 1999 to 2001. Jennifer's career began at Octel Communications as a Marketing Program Manager from 1994 to 1997.
Jennifer Oliva Herrington attended Moreau Catholic High School, but no information about their degree or field of study is provided. From 1989 to 1994, they studied at San Jose State University, earning a Bachelor's Degree in Biology with a minor in Chemistry. Additionally, in 1992 to 1993, Jennifer studied Marine Biology and Biological Oceanography at Northeastern University, but there is no information on whether they obtained a degree from this institution.
This person is not in any offices
Semler Scientific
1 followers
Semler Scientific, Inc. is a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Semler Scientific's mission is to develop, manufacture and market innovative products that assist its customers in evaluating and treating chronic diseases. Semler Scientific commercially launched its first patented and FDA- cleared product in 2011, and received FDA 510(k) clearance for QuantaFlo®, the next generation version of this product, in 2015. QuantaFlo® is a rapid point-of-care test that measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease. QuantaFlo® is used by Semler Scientific's customers to more comprehensively evaluate their patients for risk of heart attacks and strokes. Semler Scientific believes it is positioned to provide valuable information to its insurance company and physician customers, which in turn permits them to better guide patient care.